A tool to help women with substance use disorders make reproductive decisions after childbirth
Official title: Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
Run by University of Pittsburgh · NCT04939012 · Data updated 2026-11-12
This study is testing a new tool called MyPath to help women with substance use disorders make better choices about birth control after having a baby.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 400 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | October 11, 2022 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | February 17, 2026 |
| Trial ID | NCT04939012 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18 and older who are pregnant or within 9 days postpartum and have a substance use disorder.
✕Probably not a fit
Patients who have experienced fetal or neonatal death in their current pregnancy or are currently incarcerated may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of MyPath, a patient-centered decision support tool designed to improve postpartum contraceptive decision-making among women with substance use disorders (SUDs). The research addresses the high rates of unintended pregnancies in this population by providing tailored reproductive planning support during a critical period of increased healthcare access. Participants will receive either the MyPath intervention or usual care, with the goal of enhancing their contraceptive choices and aligning them with their reproductive goals. The study aims to fill a significant gap in postpartum care for women with SUDs, who often face barriers to effective contraceptive use.
Why it matters
Potential benefit: If successful, this tool could significantly reduce unintended pregnancies among women with substance use disorders.
How similar studies have gone: While there is limited research specifically targeting this approach, the study builds on previous observational findings regarding contraceptive choices in women with opioid use disorder.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Prenatal Cohort: * Be greater than or equal to 18 years of age. * Be pregnant with an EGA of 22 to 37 weeks at enrollment. * Plan to deliver at research site. * Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record. Postpartum Cohort: * Be greater than or equal to 18 years of age. * Be 0-9 days postpartum at enrollment. * Have delivered at research site. * Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record. Exclusion Criteria: * Have had a fetal or neonatal death with their current pregnancy. * Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded. * Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation. * PPC ONLY: Documented tubal ligation or hysterectomy procedures at time of delivery hospitalization
Where it's running
-
Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Elizabeth Krans, MD — University of Pittsburgh
- Study coordinator: Elizabeth Krans, MD
- Email: kransee@upmc.edu
- Phone: (412) 641-3532
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Helping mothers with substance use issues during pregnancy
This study is trying out a program to help mothers who have used drugs or alcohol during pregnancy get support and resources to build healthier lives for themselves and their children.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.